Melanocortin Receptors and Peptides: What the Latest Research Shows

Melanocortin receptors are a family of proteins found throughout the body that respond to a group of peptide hormones called melanocortins. These receptors control an impressive range of biological processes, from skin color to hunger to immune function. Research into melanocortin peptides has already produced approved drugs, and the pipeline of new candidates is growing fast.

What Are Melanocortin Receptors?

Melanocortin receptors (MCRs) are a family of five closely related G-protein coupled receptors, labeled MC1R through MC5R. Each receptor responds to melanocortin peptides and is expressed in different tissues throughout the body.

All five receptors are activated by the same group of peptides, which include alpha-MSH, beta-MSH, gamma-MSH, and ACTH. However, each receptor has different binding preferences and triggers different effects depending on where it is located.

"MC4R deficiency is now recognized as the most common monogenic form of obesity, affecting up to 6% of severely obese individuals, and therapeutic targeting of this pathway represents a paradigm shift in precision medicine for metabolic disease.", Roger Cone, Director of the Life Sciences Institute, Annual Review of Physiology (2021)

The Five Melanocortin Receptors and Their Functions

MC1R: Skin Pigmentation and Inflammation

MC1R is expressed mainly in melanocytes, the cells that produce skin pigment. When alpha-MSH binds to MC1R, it stimulates the production of eumelanin, the dark form of melanin that darkens the skin and provides protection against UV radiation.

Variants in the MC1R gene are associated with red hair, fair skin, and increased susceptibility to melanoma. MC1R is also expressed on immune cells, where its activation reduces inflammation, making it a target for inflammatory skin diseases.

MC2R: Stress Response and Cortisol

MC2R is the receptor for ACTH (adrenocorticotropic hormone) in the adrenal glands. When the pituitary gland releases ACTH, it binds to MC2R on adrenal cortex cells and stimulates the production of cortisol.

Cortisol is the body's main stress hormone and also has potent anti-inflammatory effects. Disorders of MC2R signaling are involved in conditions like Cushing's syndrome and adrenal insufficiency.

MC3R: Energy Balance and Feeding

MC3R is expressed in the brain, particularly in regions that control energy balance. It plays a role in regulating food intake and how efficiently the body uses energy.

Mice with deleted MC3R genes are more prone to obesity and insulin resistance. Human studies suggest that MC3R variants may contribute to obesity risk, and this receptor is being studied as a drug target for metabolic disease.

MC4R: The Master Regulator of Appetite

MC4R is the most intensively studied of all the melanocortin receptors. It is expressed throughout the hypothalamus, the brain region that controls appetite and body weight.

When alpha-MSH binds to MC4R, appetite is suppressed and energy expenditure increases. Blocking MC4R has the opposite effect, increasing hunger and promoting weight gain.

Mutations in MC4R are the most common single-gene cause of severe childhood obesity. About 5 to 6 percent of severely obese children carry a damaging MC4R variant. This discovery drove the development of setmelanotide, an MC4R-targeting peptide drug approved by the FDA.

MC5R: Exocrine Gland Function

MC5R is expressed in exocrine glands, including sebaceous glands, lacrimal glands, and the pancreas. It controls the secretion of oils and other fluids from these glands.

Research has linked MC5R to acne, dry eye disease, and possibly immune regulation. It is the least studied of the five receptors but is receiving increasing attention as drug discovery tools improve.

All five melanocortin receptors evolved from a single ancestral gene, yet they control functions as different as skin color, appetite, stress hormones, and immune response.

Natural Melanocortin Peptides: Structure and Activity

The natural melanocortin peptides all share a common core sequence called the "pharmacophore," which is the His-Phe-Arg-Trp (HFRW) motif. This four-amino acid sequence is the part of the peptide that actually binds to and activates the melanocortin receptors.

Alpha-MSH is a 13-amino acid peptide produced by the pituitary gland and several other tissues. It is derived from a larger protein called pro-opiomelanocortin (POMC), which is also the precursor for ACTH, beta-endorphin, and several other biologically important peptides.

Setmelanotide: The First Approved Melanocortin Peptide Drug

Setmelanotide (Imcivree) is a cyclic, synthetic MC4R agonist approved by the FDA in 2020 for treating obesity caused by genetic defects in the POMC pathway. It is the first drug approved specifically for melanocortin pathway-related obesity.

In clinical trials, setmelanotide produced significant weight loss in patients with POMC, PCSK1, or LEPR deficiencies that had previously been untreatable. Patients lost an average of 25 percent of their body weight over one year of treatment.

Setmelanotide is administered as a daily subcutaneous injection. The drug demonstrates how cyclization of a natural peptide sequence can produce a highly effective, stable drug with precisely targeted activity.

When recruiting for melanocortin drug development programs, prioritize candidates with GPCR selectivity screening experience, since the biggest bottleneck in this space is designing peptides that activate one receptor subtype without triggering the other four.

Bremelanotide: Melanocortins and Sexual Function

Bremelanotide (Vyleesi) is an MC4R-activating peptide approved for treating hypoactive sexual desire disorder in premenopausal women. It is administered as an on-demand injection before anticipated sexual activity.

Bremelanotide activates melanocortin receptors in the central nervous system, increasing sexual motivation. Its approval demonstrated that melanocortin pathways in the brain regulate sexual function, a finding that has opened new areas of research.

Anti-Inflammatory Applications of Melanocortin Peptides

Melanocortin receptors are expressed on many types of immune cells, including macrophages, neutrophils, and T cells. When activated, these receptors reduce the production of inflammatory cytokines.

Alpha-MSH and synthetic melanocortin analogs have shown strong anti-inflammatory effects in animal models of inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, and uveitis. Several of these are being advanced into clinical trials.

According to researchers at the University of Catania in Italy, one of the most active centers for melanocortin research, "The anti-inflammatory properties of melanocortin peptides are broad and potent, acting through multiple pathways simultaneously. This makes them attractive candidates for diseases where inflammation is the central driver of damage."

Melanocortin Antagonists: The Other Side of the Story

While most therapeutic efforts focus on activating melanocortin receptors, there is also value in blocking them in certain contexts. MC4R antagonists, for example, could be useful for treating cachexia (severe muscle wasting) in cancer patients, where appetite suppression is harmful.

Agouti-related protein (AgRP) is the body's natural MC4R antagonist. It opposes alpha-MSH signaling and promotes hunger. Understanding the balance between MC4R agonists and antagonists has been a major focus of obesity research.

Designing Better Melanocortin Peptide Drugs

The natural melanocortin peptides degrade quickly in the body. Most drug development programs focus on making stable, selective analogs.

Key strategies include cyclization of the peptide backbone, substitution of D-amino acids to resist protease attack, incorporation of non-natural amino acids to improve receptor subtype selectivity, and PEGylation to extend half-life.

For a detailed overview of cyclization chemistry as it applies to peptide drug development, see our guide on peptide cyclization chemistry techniques. You can also read about how inflammation-resolving peptides connect to melanocortin biology in our article on how peptides resolve inflammation.

For comprehensive research data on melanocortin receptors and their pharmacology, the IUPHAR/BPS Guide to Pharmacology provides detailed receptor profiles and drug listings.

MC4R's role as the most common genetic driver of severe obesity makes melanocortin peptide expertise one of the fastest growing hiring needs across pharma and biotech.

FAQs

What are melanocortin receptors? They are a family of five G-protein coupled receptors (MC1R through MC5R) that are activated by melanocortin peptides. They control pigmentation, appetite, cortisol production, inflammation, sexual function, and other processes.

What is alpha-MSH? Alpha-MSH (alpha-melanocyte-stimulating hormone) is a 13-amino acid peptide produced by the pituitary gland and other tissues. It activates melanocortin receptors throughout the body and is involved in skin pigmentation, appetite regulation, and immune modulation.

What is setmelanotide and what is it used for? Setmelanotide (Imcivree) is an FDA-approved cyclic peptide MC4R agonist used to treat severe obesity caused by certain genetic mutations in the POMC signaling pathway. It is the first drug specifically approved for this type of genetic obesity.

Why is MC4R so important for weight control? MC4R in the hypothalamus is a key regulator of appetite. When activated by alpha-MSH, it suppresses hunger and increases energy expenditure. Mutations that reduce MC4R function are the most common single-gene cause of severe childhood obesity.

Can melanocortin peptides treat inflammation? Research shows that melanocortin receptors on immune cells reduce cytokine production when activated. Alpha-MSH and synthetic melanocortin analogs have shown anti-inflammatory effects in multiple disease models, and clinical trials are ongoing.

What is AgRP? Agouti-related protein (AgRP) is a natural peptide in the brain that acts as an MC4R antagonist. It competes with alpha-MSH for receptor binding and promotes hunger, making it an important part of the body's appetite regulation system.